Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3353-3356

  Feuerriegel, Silke ^a   Cox, Helen S ^b   Zarkua, Nana ^c   Karimovich, Hamraev A ^d   Braker, Kai ^c   Rüsch Gerdes, Sabine ^a   Niemann, Stefan ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d Ministry of Health   (Uzbekistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CAPREOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; OFLOXACIN;

ARTICLE; BACTERIAL STRAIN; CODON; CONTROLLED STUDY; DNA SEQUENCE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; GENE TARGETING; MOLECULAR GENETICS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UZBEKISTAN;

AMIKACIN; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CAPREOMYCIN; DNA GYRASE; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; UZBEKISTAN;

EID: 67749120061     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00050-09     Document Type: Article

References (28)

1. Alangaden, G. J., B. N. Kreiswirth, A. Aouad, M. Khetarpal, F. R. Igno, S. L. Moghazeh, E. K. Manavathu, and S. A. Lerner. 1998. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:1295-1297.
2. Aubry, A., N. Veziris, E. Cambau, C. Truffot-Pernot, V. Jarlier, and L. M. Fisher. 2006. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrob. Agents Chemother. 50:104-112.
3. Bang, D., A. A. Bengard, and V. O. Thomsen. 2006. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J. Clin. Microbiol. 44:2605-2608.
4. Cox, H. S., S. Kalon, S. Allamuratova, V. Sizaire, Z. N. Tigay, S. Rusch-Gerdes, H. A. Karimovich, Y. Kebede, and C. Mills. 2007. Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures. PLoS One 2:e1126.
5. Cox, H. S., K. Sibilia, S. Feuerriegel, S. Kalon, J. Polonsky, A. K. Khamraev, S. Rusch-Gerdes, C. Mills, and S. Niemann. 2008. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis. N. Engl. J. Med. 359:2398-2400.
6. De Rossi, E., J. A. Ainsa, and G. Riccardi. 2006. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol. Rev. 30:36-52.
7. Deutsches Institut für Normung e.V. 2009. Methods for the determination of susceptibility of tubercle bacilli to chemotherapeutic agents. Norm 58943, Part 8. Deutsches Institut für Normung e.V., Berlin, Germany.
8. Hillemann, D., S. Rusch-Gerdes, and E. Richter. 2007. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640.
9. Jain, A., and R. Mondal. 2008. Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol. Med. Microbiol. 53:145-150.
10. Johansen, S. K., C. E. Maus, B. B. Plikaytis, and S. Douthwaite. 2006. Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2′-O-methylations in 16S and 23S rRNAs. Mol. Cell 23:173-182.
11. Kocagoz, T., C. J. Hackbarth, I. Unsal, E. Y. Rosenberg, H. Nikaido, and H. F. Chambers. 1996. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 40:1768-1774.
12. Loddenkemper, R., D. Sagebiel, and A. Brendel. 2002. Strategies against multidrug-resistant tuberculosis. Eur. Respir. J. Suppl. 36:66s-77s.
13. Makinen, J., H. J. Marttila, M. Marjamaki, M. K. Viljanen, and H. Soini. 2006. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 44:350-352.
14. Maus, C. E., B. B. Plikaytis, and T. M. Shinnick. 2005. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:3192-3197.
15. Maus, C. E., B. B. Plikaytis, and T. M. Shinnick. 2005. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:571-577.
16. Pasca, M. R., P. Guglierame, F. Arcesi, M. Bellinzoni, E. De Rossi, and G. Riccardi. 2004. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48: 3175-3178.
17. Pfyffer, G. E., D. A. Bonato, A. Ebrahimzadeh, W. Gross, J. Hotaling, J. Kornblum, A. Laszlo, G. Roberts, M. Salfinger, F. Wittwer, and S. Siddiqi. 1999. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J. Clin. Microbiol. 37:3179-3186.
18. Piersimoni, C., A. Olivieri, L. Benacchio, and C. Scarparo. 2006. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J. Clin. Microbiol. 44: 20-28.
19. Pitaksajjakul, P., W. Wongwit, W. Punprasit, B. Eampokalap, S. Peacock, and P. Ramasoota. 2005. Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand. Southeast Asian J. Trop. Med. Public Health 36(Suppl. 4):228-237.
20. Rinder, H., K. T. Mieskes, and T. Loscher. 2001. Heteroresistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 5:339-345.
21. Rusch-Gerdes, S., G. E. Pfyffer, M. Casal, M. Chadwick, and S. Siddiqi. 2006. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J. Clin. Microbiol. 44:688-692.
22. Sanger, F., S. Nicklen, and A. R. Coulson. 1992. DNA sequencing with chain-terminating inhibitors. 1977. Biotechnology 24:104-108.
23. Suzuki, Y., C. Katsukawa, A. Tamaru, C. Abe, M. Makino, Y. Mizuguchi, and H. Taniguchi. 1998. Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J. Clin. Microbiol. 36:1220-1225.
24. Takiff, H. E., L. Salazar, C. Guerrero, W. Philipp, W. M. Huang, B. Kreiswirth, S. T. Cole, W. R. Jacobs, Jr., and A. Telenti. 1994. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.
25. Van Soolingen, D., P. W. Hermans, P. E. de Haas, D. R. Soll, and J. D. Van Embden. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequencedependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
26. Veziris, N., C. Martin, F. Brossier, F. Bonnaud, F. Denis, and A. Aubry. 2007. Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance. Eur. J. Clin. Microbiol. Infect. Dis. 26:423-425.
27. Wang, J. Y., L. N. Lee, H. C. Lai, S. K. Wang, I. S. Jan, C. J. Yu, P. R. Hsueh, and P. C. Yang. 2007. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J. Antimicrob. Chemother. 59:860-865.
28. World Health Organization. 2008. Tuberculosis facts. World Health Organization, Geneva, Switzerland. www.who.int/tb.